← FDA Drug Approvals (Drugs@FDA)
RANITIDINE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: THINQ PHARM-CRO PVT · Approved 2019-08-30
Drug application
- FDA Application #
ANDA210228- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RANITIDINE HYDROCHLORIDE
- Generic name
- Ranitidine Hydrochloride
- Active ingredients
- RANITIDINE HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- THINQ PHARM-CRO PVT
- First approval
- 2019-08-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown